首页> 外文期刊>Journal of AOAC International >Silver Nanoparticles Synthesis for Sensitive Spectrophotometric Determination of Sofosbuvir, Lamivudine, and Ritonavir in Pure Forms and Pharmaceutical Dosage Forms
【24h】

Silver Nanoparticles Synthesis for Sensitive Spectrophotometric Determination of Sofosbuvir, Lamivudine, and Ritonavir in Pure Forms and Pharmaceutical Dosage Forms

机译:纯度和药物剂型中Sofosbuvir,Lamivudine和Ritonavir敏感分光光度法的银纳米粒子合成

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Silver nanoparticles synthesis is now widely applicable as a method for sensitive spectrophotometric determination of many pharmaceuticals. Objective: A highly sensitive, cheap, green, nonextractive, and accurate spectrophotometric method was developed for the determination of three important antiviral drugs. Methods: The method depends on the formation of silver nanoparticles as a result of the redox reaction between antiviral drugs as a reducing agent and AgNO3 as an oxidizing agent in presence of polyvinyl pyrrolidone as a stabilizing agent. The UV absorbance of the resulted golden yellow silver nanoparticles can be easily measured at 421 nm for Sofosbuvir (SFS) and Ritonavir (RIT) and at 425 nm for Lamivudine (LAM). Results: The LODs were 23.5, 30, and 21.5 nm/mL for SFS, LAM, and RIT, respectively. The LOQs were 70.5, 90, and 64.6 nm/mL for SFS, LAM, and RIT, respectively. The method was validated according to International Conference on Harmonization guidelines, and it was successively applied for the determination of the studied drugs in their different pharmaceutical dosage forms and gave excellent percent of recovery. The results showed excellent agreement with the reported method with respect to precision and accuracy. Conclusions: Being simple, fast, robust, and economic, this method is eligible for use in the routine work in pharmaceutical quality control laboratories. Highlights: A sensitive and economic spectrophotometric method was developed and validated for quantitative determination of SFS, LAM, and RIT. The method was validated and applied for determination of the studied drugs in their different formulations. The method used water as the main solvent, so our proposed method is considered environmentally friendly.
机译:背景:银纳米颗粒合成现在广泛适用于敏感分光光度法测定许多药物的方法。目的是开发出高度敏感,廉价,绿色,非激动的和准确的分光光度法,用于测定三种重要的抗病毒药物。方法:该方法取决于作为抗病毒药物作为还原剂的氧化还原反应作为还原剂的氧化还原反应,作为氧化剂作为稳定剂的聚乙烯吡咯烷酮的氧化剂。所产生的金黄色银纳米粒子的UV吸光度可以在421nm上以421nm易于测量Sofosbuvir(SFS)和Ritonavir(Rit),并在425nm中用于拉米夫定(LAM)。结果:SFS,LAM和RIT分别为23.5,30和21.5nm / ml。对于SFS,LAM和RIT,LOQs分别为70.5,90和64.6nm / ml。该方法根据协调指南国际会议验证,并先后申请了以不同的药物剂型确定研究的药物,并提供了优异的恢复百分比。结果表明,与精度和准确性相比,与报告的方法均匀。结论:简单,快速,强劲,经济,这种方法有资格在制药质量控制实验室的常规工作中使用。亮点:开发并验证了一种敏感和经济分光光度法,用于定量测定SFS,LAM和Rit的测定。该方法经过验证并应用于不同配方中研究的药物。该方法用水作为主要溶剂,所以我们所提出的方法被认为是环保的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号